Sorrento Therapeutics Inc (SRNE): Will the next news be about COVISTIX EUA...

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	57
Posts	5700
Boards Moderated	0
Alias Born	12/13/2004

dia76ca

Re: None

Monday, 01/03/2022 3:39:47 PM

Monday, January 03, 2022 3:39:47 PM

Will the next news be about COVISTIX EUA's or sales? Or will it be about SEMDEXA? Or about a ABIVERTINIB-centric partnership?

COVISTIX leads the way for Covid products.
SEMDEXA leads the way for pain products.
ABIVERTINIB leads the way for cancer products.

All 3 products have large blockbuster potential and all 3 are followed by other large potential products.

COVISTIX sales can pave the way for ABIVERTINIB(ARDS), COVI-AMG, COVISHIELD, COVI-MSC and COVIDROPS.

SEMDEXA sales can pave the way for SP-103, SP-104, RTX(cancer pain), and RTX(arthritic pain).

ABIVERTINIB can pave the way for a dozen ADNAB(Mayo Clinic) drugs, a dozen DAR-T drugs and various other ADC's and an oncolytic virus.

Owning Sorrento is owning 3 multi-blockbuster portfolios in one company!

"The refusal of the real is the number one dogma of our time" Rene Girard

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent SRNE News

Form 8-K - Current report • Edgar (US Regulatory) • 11/03/2023 09:31:06 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/27/2023 08:15:31 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/13/2023 01:51:06 AM
Form 8-K - Current report • Edgar (US Regulatory) • 08/28/2023 09:25:07 PM
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/07/2023 08:15:35 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2023 10:01:54 AM
Form 8-K - Current report • Edgar (US Regulatory) • 07/13/2023 10:26:26 AM